ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

INMD InMode Ltd

17.89
0.29 (1.65%)
27 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
InMode Ltd NASDAQ:INMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.29 1.65% 17.89 17.41 18.09 17.92 17.45 17.81 562,518 01:00:00

InMode to Present In-Person at the Barclays Global Health Conference

02/03/2023 1:30pm

PR Newswire (US)


InMode (NASDAQ:INMD)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more InMode Charts.

YOKNEAM, Israel, March 2, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Barclays Global Health Conference in Miami on March 15, 2023.

The fireside chat, moderated by Matt Miksic, equity research analyst, is scheduled for 9:30 am Eastern Time on Wednesday, March 15 and will be webcast from InMode's Investor Relations website at https://inmodemd.com/investors/. InMode will also hold one-on-one investor meetings in person that same day. To schedule a meeting, please contact your Barclays representative.

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 
917-607-8654 

Cision View original content:https://www.prnewswire.com/news-releases/inmode-to-present-in-person-at-the-barclays-global-health-conference-301758856.html

SOURCE InMode LTD

Copyright 2023 PR Newswire

1 Year InMode Chart

1 Year InMode Chart

1 Month InMode Chart

1 Month InMode Chart